More on VKTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $31.51 |
|
|||
| Open | $30.89 | ||||
| 52 Wk High | $5.17 | ||||
| 52 Wk Low | $0.94 | ||||
| Day High | $33.20 | ||||
| Day Low | $30.46 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,969,647 | ||||
- Viking Therapeutics to Participate at Upcoming Investor Conferences
- Truist on Viking Therapeutic (VKTX): 'Riding High On A Winning (GLP+GIP) Combination As Commercial Strategy Takes Shape'
- Viking Therapeutic (VKTX) PT Lowered to $99 at Morgan Stanley
- Viking Therapeutic (VKTX) PT Lowered to $118 at Raymond James
- Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)
- Form 10-K Viking Therapeutics, For: Dec 31
- Viking Therapeutics (VKTX) Misses Q4 EPS by 48c
- Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
- Form 8-K Viking Therapeutics, For: Feb 11
- Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
Entities mentioned with VKTX
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- H.C. Wainwright | View Related Stories »
- William Blair | View Related Stories »
- Show More...
